Literature DB >> 9390722

Validated assay for the quantification of anastrozole in human plasma by capillary gas chromatography-63Ni electron capture detection.

M J Bock1, I Bara, N LeDonne, A Martz, M Dyroff.   

Abstract

An assay was developed for the quantification of anastrozole [2,2'-[5-(1H-1,2,4-triazol-1-ymethyl)-1,3-phenylene]bis(2-++ +methylpropiononitrile)] in human plasma using liquid-liquid extraction. Anastrozole and an internal standard were chromatographed and detected by gas chromatography with electron capture detection, using a combination temperature-pressure program. The range of the assay is 3 to 100 ng/ml. Anastrozole was quantified by comparing its peak area to that of an internal standard. A cross-validation of this assay was also successfully performed between several laboratories.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9390722     DOI: 10.1016/s0378-4347(97)00129-1

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  4 in total

1.  Formulation of anastrozole microparticles as biodegradable anticancer drug carriers.

Authors:  Ahmed S Zidan; Omaima A Sammour; Mohammed A Hammad; Nagia A Megrab; Muhammad D Hussain; Mansoor A Khan; Muhammad J Habib
Journal:  AAPS PharmSciTech       Date:  2006-07-21       Impact factor: 3.246

2.  The effect of anastrozole on the single-dose pharmacokinetics and anticoagulant activity of warfarin in healthy volunteers.

Authors:  R A Yates; J Wong; M Seiberling; M Merz; W März; M Nauck
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335

3.  Sustained release optimized formulation of anastrozole-loaded chitosan microspheres: in vitro and in vivo evaluation.

Authors:  Gopal V Shavi; Usha Y Nayak; M Sreenivasa Reddy; A Karthik; Praful B Deshpande; A Ranjith Kumar; N Udupa
Journal:  J Mater Sci Mater Med       Date:  2011-03-23       Impact factor: 3.896

4.  Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex and tamoxifen alone or in combination' (ATAC) trial.

Authors:  M Dowsett; J Cuzick; A Howell; I Jackson
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.